Liposomal cancer chemotherapy: current clinical applications and future prospects.
about
Partially polymerized liposomes: stable against leakage yet capable of instantaneous release for remote controlled drug delivery.Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice.DOXO-EMCH (INNO-206): the first albumin-binding prodrug of doxorubicin to enter clinical trials.Biodistribution and pharmacokinetics of 111In-dTPA-labelled pegylated liposomes after intraperitoneal injection.
P2860
Liposomal cancer chemotherapy: current clinical applications and future prospects.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Liposomal cancer chemotherapy: current clinical applications and future prospects.
@ast
Liposomal cancer chemotherapy: current clinical applications and future prospects.
@en
Liposomal cancer chemotherapy: current clinical applications and future prospects.
@nl
type
label
Liposomal cancer chemotherapy: current clinical applications and future prospects.
@ast
Liposomal cancer chemotherapy: current clinical applications and future prospects.
@en
Liposomal cancer chemotherapy: current clinical applications and future prospects.
@nl
prefLabel
Liposomal cancer chemotherapy: current clinical applications and future prospects.
@ast
Liposomal cancer chemotherapy: current clinical applications and future prospects.
@en
Liposomal cancer chemotherapy: current clinical applications and future prospects.
@nl
P2860
P1476
Liposomal cancer chemotherapy: current clinical applications and future prospects.
@en
P2093
Harrington KJ
P2860
P304
P356
10.1517/13543784.10.6.1045
P407
P577
2001-06-01T00:00:00Z